No profile data available.
Kalaris Therapeutics, Inc. (KLRS) is a healthcare company in the antiviral pharmaceuticals industry, based in Berkeley Heights, United States, with about 20 full-time employees.
It reported revenue of $0 for fiscal year 2025, and net income of -$43.44 million. Its market capitalization was $56.18 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
, a clinical-stage biopharmaceutical company, engages in the development and commercialization of treatments for prevalent retinal diseases.
Kalaris Therapeutics reported $0 in revenue for fiscal year 2025.
$56.18 million as of October 9, 2026.
Listed companies of a similar size in the same industry (antiviral pharmaceuticals) include Invivyd, Inc. (IVVD), Vaxart, Inc. (VXRT), Verrica Pharmaceuticals Inc. (VRCA), Serina Therapeutics, Inc. (SER).